D. Enever

411 total citations
6 papers, 284 citations indexed

About

D. Enever is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, D. Enever has authored 6 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Genetics. Recurrent topics in D. Enever's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Mesenchymal stem cell research (3 papers) and Transplantation: Methods and Outcomes (3 papers). D. Enever is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Mesenchymal stem cell research (3 papers) and Transplantation: Methods and Outcomes (3 papers). D. Enever collaborates with scholars based in Australia. D. Enever's co-authors include Stephanie T. Yerkovich, Daniel C. Chambers, Peter Hopkins, Kerry Atkinson, Dalia Khalil, Lisa Sparks, Nina Ilić, Sharon Lawrence, Marian Sturm and Michael Musk and has published in prestigious journals such as The Journal of Heart and Lung Transplantation, Stem Cells Translational Medicine and Respirology.

In The Last Decade

D. Enever

6 papers receiving 272 citations

Peers

D. Enever
Haijiang Tong China
Ellen Mønsted Johansen Denmark
Nadim Srour Canada
Meng‐Xia Deng China
W. Massoud France
Shinya Yokote Japan
Holger Karbach Sweden
Alexandre Slater United Kingdom
Darcie J. Radel United States
Francesca Braschi Italy
Haijiang Tong China
D. Enever
Citations per year, relative to D. Enever D. Enever (= 1×) peers Haijiang Tong

Countries citing papers authored by D. Enever

Since Specialization
Citations

This map shows the geographic impact of D. Enever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Enever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Enever more than expected).

Fields of papers citing papers by D. Enever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Enever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Enever. The network helps show where D. Enever may publish in the future.

Co-authorship network of co-authors of D. Enever

This figure shows the co-authorship network connecting the top 25 collaborators of D. Enever. A scholar is included among the top collaborators of D. Enever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Enever. D. Enever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Mackintosh, John A., Viviana P. Lutzky, D. Enever, et al.. (2021). TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis. BMJ Open Respiratory Research. 8(1). e001127–e001127. 14 indexed citations
2.
Chambers, Daniel C., D. Enever, Sharon Lawrence, et al.. (2017). Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study. Stem Cells Translational Medicine. 6(4). 1152–1157. 65 indexed citations
3.
Chambers, Daniel C., D. Enever, Scott Lawrence, et al.. (2016). Results of a First-in-Man Study of Mesenchymal Stem Cell Therapy for Bronchiolitis Obliterans Syndrome. The Journal of Heart and Lung Transplantation. 35(4). S42–S43. 2 indexed citations
4.
Chambers, Daniel C., D. Enever, Nina Ilić, et al.. (2014). A phase 1b study of placenta‐derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 19(7). 1013–1018. 198 indexed citations
5.
Chambers, Daniel C., D. Enever, Nebojša Ilić, et al.. (2014). A phase 1b study of mesenchymal stromal cell therapy for idiopathic pulmonary fibrosis. Cytotherapy. 16(4). S12–S12. 4 indexed citations
6.
Chambers, Daniel C., Peter Hopkins, Scott Lawrence, et al.. (2012). 176 Mesenchymal Stromal Cell Therapy for Bronchiolitis Obliterans Syndrome – Preliminary Data in Humans. The Journal of Heart and Lung Transplantation. 31(4). S67–S68. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haijiang Tong Breakdown of academic impact, for papers by Ellen Mønsted Johansen Breakdown of academic impact, for papers by Nadim Srour Breakdown of academic impact, for papers by Meng‐Xia Deng Breakdown of academic impact, for papers by W. Massoud Breakdown of academic impact, for papers by Shinya Yokote Breakdown of academic impact, for papers by Holger Karbach Breakdown of academic impact, for papers by Alexandre Slater Breakdown of academic impact, for papers by Darcie J. Radel Breakdown of academic impact, for papers by Francesca Braschi
Rankless by CCL
2026